Arthritis in Juvenile Patients
📧 Sign up to get email alerts when something new happens for Arthritis in Juvenile Patients.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Taltz (ixekizumab) — Eli Lilly and Company (Ireland) Limited
EMA authorised Taltz (ixekizumab) for multiple indications including psoriasis, psoriatic arthritis, axial spondyloarthritis, and juvenile a…